RBM47

Across TCGA pan-cancer cohorts, RBM47 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of RBM47’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RBM47 RNA is repressed in tumor relative to normal tissue. In most cancer types RBM47 is over-expressed in tumor, although a few such as COAD and HNSC show the opposite, repressed pattern.

COAD, HNSC, and THCA are the cancer types where RBM47 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBM47 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	IV	−1.314	<.001	12	view →
HNSC	All	II,III,IV	−0.944	<.001	10	view →
THCA	Male	III,IV	−0.990	<.001	9	view →
KIRC	Male	II,III,IV	−0.895	<.001	9	view →
BRCA	All	III,IV	+1.217	<.001	6	view →
CHOL	Male	All	+1.380	<.001	5	view →
READ	All	All	−1.273	<.001	5	view →
LUSC	Male	All	−0.798	<.001	5	view →
STAD	All	All	+1.121	.007	3	view →
KIRP	Male	All	−0.439	.011	3	view →
BLCA	All	IV	+2.177	.016	2	view →
UCEC	All	All	+1.453	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

RBM47–COAD

Open the COAD breakdown →